Abous Us

Corporate profile

Grünenthal is a global leader in pain management and related diseases.

We have a long track record of bringing innovative treatments to patients worldwide. As a fully integrated pharmaceutical company, we cover the entire value chain – from drug research and development to commercialisation of portfolios with growth products and established medicines. We operate in accordance with the highest ethical and regulatory standards. At Grünenthal, we focus our efforts on our vision of a World Free of Pain.

Grünenthal at a glance
Our virtual company showcase provides information about our key objectives and activities, as well as our recent business development highlights and financial performance.
Enter
keywords
Strong and capable team
4,400

employees worldwide

Solid revenue base
1.8

billion euros in 2023

Commercial presence in
27

countries across Europe, Latin America, and the US

Products sold in around
100

countries

International network
2

R&D sites – one R&D Unit in Aachen (Germany) and an Innovation Hub in Boston, (USA)

Production capacities
5

manufacturing sites in Europe and Latin America

MSCI recognises Grünenthal as an ESG industry leader" role. MSCI Provisional ESG Ratings (p)AA as of Oct. 2024

ESG Industry Leader

At Grünenthal, conducting our business responsibly is an integral part of our company’s strategy and culture. We aspire to create a positive impact for society – in our core business and beyond. We are guided by integrity, transparency and the highest ethical standards. Our industry-leading way of doing business responsibly is reflected in our external Environment, Social and Governance (ESG) ratings.

Responsibility
Contract Manufacturing GRT PRO

Global capabilities

Grünenthal operates five world-class manufacturing sites around the globe, where we produce all of our own products, as well as manufacturing medicines for key industry partners. We have made significant investments into our facilities and are fully committed to ensuring the quality, safety and sustainability of every medicine we produce for patients.

Presence & Sites
Pipeline

Pipeline

Our scientists have developed several life-changing pain medicines for patients. To move closer to our vision of a World Free of Pain, we are pursuing a range of programs across different modalities, targets, and mechanisms of action. 

Development Pipeline